Implantable cardioverter defibrillator in arrhythmogenic cardiomyopathy: which role for antitachycardia pacing?

Back

EHRA Premium Access

Implantable cardioverter defibrillator in arrhythmogenic cardiomyopathy: which role for antitachycardia pacing?

Session: Moderated ePosters - Basic science and a variety of arrhythmias

Topic: Device Treatment

Speaker: Doctor A. Spadotto (Geneva, CH)

Event: EHRA 2022

Congress Presentation

Add to my library

About the speaker

Doctor Alberto Spadotto

University hospitals of Geneva, Geneva (Switzerland)

1 presentation

0 follower

6 more presentations in this session

Anatomically-guided cardioneuroablation for recurrent neurally mediated syncope

Speaker: Associate Professor D. Wichterle (Prague, CZ)

Access

Abstract

Slides

QRS duration as an independent risk factor for appropriate shocks and mortality in patients with prophylactic implantable cardioverter-defibrillator

Speaker: Doctor P. Bengel (Giessen, DE)

Access

Abstract

Slides

Threshold values by electrocardiogram and echocardiography indicating transition to an arrhythmic phenotype in cardiac laminopathies: a primary prevention cohort study

Speaker: Doctor C. Rootwelt-Norberg (Oslo, NO)

Access

Abstract

Slides

Virtual induction and treatment of arrhythmias (VITA): a fast automated computational tool to induce scar-related tachycardia and identify ablation targets

Speaker: Doctor F. Campos (London, GB)

Access

Abstract

Slides

Neuronal nitric oxide synthase inhibition exacerbates atrial electrical remodeling via small-conductance Ca2+-activated K+ channel activation

Speaker: Doctor T. Koya (Sapporo, JP)

Access

Abstract

Slides

Access the full session

Moderated ePosters - Basic science and a variety of arrhythmias

Speakers: Doctor A. Spadotto, Associate Professor D. Wichterle, Doctor P. Bengel, Doctor C. Rootwelt-Norberg, Doctor F. Campos...

Access

About the event

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources